Brexpiprazole versus placebo or other antidepressive agents for treating depression
Ralovska S., Koychev I., De Crescenzo F., Marinov P., Cipriani A.
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute- and long-term treatment of major depression.